Advertisement

NinePoint Medical Inc., an in vivo pathology device maker newly headquartered in Cambridge, has closed a $33 million Series A funding round led by Third Rock Ventures and Prospect Venture Partners.

NinePoint Medical officials plan to use the financing to support medical device development and commercialization, using the company’s in vivo pathology platform; to hire 25 new employees within a year; and eventually to begin manufacturing at its Cambridge facility.

SOURCE

Advertisement
Advertisement